{"title":"Understanding the Utilization of Tertiary Hospitals by Mild Disease Patients: Travel Cost Method Analysis.","authors":"Seokmin Ji, Sewon Park, Mankyu Choi, Munjae Lee","doi":"10.2147/RMHP.S506111","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Tertiary hospital utilization for patients with mild diseases creates inefficiencies in medical utilization for medical consumers and providers, collapses the healthcare delivery system, and has negative consequences for the public health system. This study aims to identify the factors that lead to the selection of tertiary hospitals and the medical needs of patients with mild diseases. We evaluate the value of using medical institutions by comparing and analyzing regional and individual patient characteristics.</p><p><strong>Methods: </strong>The travel cost method based on the travel cost incurred according to the consumer's temporal choice, was used to evaluate the medical use. We considered data from Ajou University Hospital from 2017 to 2022. The variables used for travel costs are travel costs, time costs, and medical costs. The Quantum Geographic Information System(QGIS) network analysis was used to calculate travel costs and time costs, and independent sample <i>t</i>-tests and analysis of variance (ANOVA) were used to compare the evaluated values between groups.</p><p><strong>Results: </strong>The analysis revealed that travel costs were the highest for patients with diabetes. Regarding personal characteristics, men exhibited higher rates than women, and individuals under 65 years of age and those receiving type 2 medical benefits demonstrated higher travel costs. Travel costs and outpatient visit rates for mild diseases exhibited a direct proportional relationship. We compared the total economic value assessed for each type of mild disease and found the highest value for diabetes patients with the highest number of outpatient visits.</p><p><strong>Conclusion: </strong>These findings highlight the importance of incorporating patient segmentation into policy formulation to alleviate the overcrowding of patients with mild diseases in tertiary care hospitals. Furthermore, they advocate adopting a primary care-centered approach to enhance the healthcare delivery system and address imbalances in community healthcare resources.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"1747-1760"},"PeriodicalIF":2.7000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12125545/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S506111","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Tertiary hospital utilization for patients with mild diseases creates inefficiencies in medical utilization for medical consumers and providers, collapses the healthcare delivery system, and has negative consequences for the public health system. This study aims to identify the factors that lead to the selection of tertiary hospitals and the medical needs of patients with mild diseases. We evaluate the value of using medical institutions by comparing and analyzing regional and individual patient characteristics.
Methods: The travel cost method based on the travel cost incurred according to the consumer's temporal choice, was used to evaluate the medical use. We considered data from Ajou University Hospital from 2017 to 2022. The variables used for travel costs are travel costs, time costs, and medical costs. The Quantum Geographic Information System(QGIS) network analysis was used to calculate travel costs and time costs, and independent sample t-tests and analysis of variance (ANOVA) were used to compare the evaluated values between groups.
Results: The analysis revealed that travel costs were the highest for patients with diabetes. Regarding personal characteristics, men exhibited higher rates than women, and individuals under 65 years of age and those receiving type 2 medical benefits demonstrated higher travel costs. Travel costs and outpatient visit rates for mild diseases exhibited a direct proportional relationship. We compared the total economic value assessed for each type of mild disease and found the highest value for diabetes patients with the highest number of outpatient visits.
Conclusion: These findings highlight the importance of incorporating patient segmentation into policy formulation to alleviate the overcrowding of patients with mild diseases in tertiary care hospitals. Furthermore, they advocate adopting a primary care-centered approach to enhance the healthcare delivery system and address imbalances in community healthcare resources.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.